SMAD9 and Hodgkins lymphoma: Our data showed that deregulation of the BMP-pathway via overexpression of inhibitory SMAD9 contributed to TLX2 activation in HL, demonstrating that aberrations in this pathway underlie deregulation of NKL homeobox genes in both T-ALL and HL.